Navigation Links
Fortified Milk Reduces Morbidity in Preschool Children

Consumption of milk fortified with specific micronutrients—zinc, iron, selenium, copper, vitamin A, vitamin C and vitamin E—significantly reduce diarrhea and acute lower// respiratory illness among children in developing countries, according to researchers from the Johns Hopkins Bloomberg School of Public Health and the Center for Micronutrient Research at Annamalai University in India. The study was published November 28, 2006, on the website of the British Medical Journal.

“Some micronutrients have a crucial role in generation, maintenance and amplification of immune responses in the body. Deficiencies in multiple micronutrients among preschool children are an important determinant of child health in developing countries,” said Sunil Sazawal, MD, MPH, PhD, lead author of the study and an associate professor in the Bloomberg School of Public Health’s Department of International Health.

The authors conducted a randomized, controlled trial among 633 children aged 1-4 years in a peri-urban population in New Delhi, India, from April 2002-April 2004. An intervention group of 316 children received milk fortified with additional micronutrients—7.8 mg zinc, 9.6 mg iron, 4.2 μg selenium, 0.27 mg copper, 156 μg vitamin A, 40.2 mg vitamin C and 7.5 mg vitamin E—while a control group of 317 children received the same milk without fortification. The study was undertaken in children over 12 months of age, of which breast feeding is not the primary source of nutrition.

The children who received fortified milk had fewer episodes of diarrhea and acute lower respiratory illness (pneumonia). Fortified milk reduced the number of days with severe illness by 15 percent, the number of days with high fever by 7 percent, the incidence of diarrhea by 18 percent and the incidence of pneumonia by 26 percent.

“Together, these results suggest an improved immunity against common infections in children,” said Robert E. Black, MD, MPH, co-author of th
'"/>




Page: 1 2

Related medicine news :

1. Fortified iron in diets may increase the risk of cancer
2. One Mans Fortified Bread is Anothers Poison
3. Drug Reduces Risk of Clogged Arteries, Veins
4. Sunshine Reduces MS Risk
5. Estrogen in Food Reduces Cancer Risk
6. Dental Procedure Reduces Preterm Births
7. Vaccine Reduces antibiotic-resistant infections in Children
8. Eating Fiber Reduces The Risk Of Heart Disease
9. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
10. Anti-tobacco Advertising Can Reduces smoking Among Teens
11. Eating Fish Reduces Heart Disease
Post Your Comments:
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... The Drug Information Association ...ill host the Critical Path Initiative (CPI) on the...16; Bethesda, MD) and the Critical Path Transporte... Horsham, PA (PRWEB) July 25...mation Association (DIA)] and the Food and Drug Ad...
(Date:7/24/2008)...TON-SALEM, N.C. Researchers at Wake Forest Unive...-standing clinical belief that the hepatitis C vir...restore itself after HIV patients are treated with..., Hepatitis C (HCV) infection is more serious in...e, according to the Centers for Disease Control. I...
(Date:7/24/2008)...UTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 ... to report its 2008 second quarter and,year-to-dat...second quarter,and year-to-date financial results ...ding hours., The company will host a conference c...m. Eastern Time) on Tuesday, July 29, 2008. ev3,ma...
Breaking Medicine News(10 mins):Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2
...s usually indicated by itchy flaky scalp to give ...say you can treat dandruff by using a medicated sh...brands from time to time, as individual products m...air with the shampoo every day or so, and make sur...
...ling over visions of adult stem cells as a less ho...lternative to embryonic stem cells, whose ability ...between those who think such research destroys a l...l. The new findings challenge the notion adult ste...
...potato may become a reality some day, according to...that// muscle cells use to build strength and endu...may be possible to develop a pill that pumps up mu...said Dr. R. Sanders Williams, dean of the Duke Uni...
...ound in fish oil halves the risk of sudden death i...und that eating oily fish such as tuna and salmon ...ed by a particular type of irregular heartbeat. Th...han dietary fish oil, could be a therapy without s...
Other Medicine News:Health News:A question on study of Adult Stem Cell 2Health News:A question on study of Adult Stem Cell 3
(Date:7/22/2008)...s Including Lantus(R) and Apidra(R) Resulted in Si... 2 Diabetes, Whatever the Algorithm ...22 /- Results from the "Adjust to,Tar...orithm to Carbohydrate,Counting for Adjustment of ...in the American Diabetes Association,s (ADA) medic...
(Date:7/22/2008)... treatment with chemotherapy and pegylated enzyme ...ed to chemotherapy alone - - Pegy... /- Halozyme Therapeutics,... developing and,commercializing products targeting...sentation of positive pre-clinical animal efficacy...
(Date:7/22/2008)...IPOLIS, France, July 22 /- ...t has successfully completed the,enrollment of 417...rtension,in two clinical pharmacology studies in t...d timelines. These trials are designed to assess t...rison to ibuprofen and,naproxen, using the Ambulat...
(Date:7/21/2008)...ing to focus on use of Zevalin as consolidation th...reated patients with follicular ...re-FirstCall/ -- Cell Therapeutics, Inc.,(CTI) (Na...ny has scheduled,a meeting with the U.S. Food and ...the possibility of filing a supplemental Biologics...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4American Chemical Societys Weekly Presspac Sept 5 2007 853 1American Chemical Societys Weekly Presspac Sept 5 2007 853 2American Chemical Societys Weekly Presspac Sept 5 2007 853 3American Chemical Societys Weekly Presspac Sept 5 2007 853 4American Chemical Societys Weekly Presspac Sept 5 2007 853 5American Chemical Societys Weekly Presspac Sept 5 2007 853 6American Chemical Societys Weekly Presspac Sept 5 2007 853 7American Chemical Societys Weekly Presspac Sept 5 2007 853 8American Chemical Societys Weekly Presspac Sept 5 2007 853 9Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 1Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference 848 2Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 1Biomoda Inc and Quintiles Announce Agreement for Regulatory Consulting 843 2Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 1Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 450 2
...Closure of Multi-Center Trial in 4 Weeks Reinforce...s in Myeloma-, NORTH HOLLYWOOD, Calif., May 15, 20...ation (IMF) - supporting research and,providing ed...,families, researchers and physicians - today sai...enter myeloma trial using,REVLIMID(R) has demonstr...
... Poster Presented at Society for Investigative Der.../ -- AGI Dermatics,recently announced new comparat...cells have the ability to recognize, transport and...nst oxidative,damage, and importantly, that (EGT) ...than idebenone, scavenging reactive oxygen,species...
Other Medicine Technology:The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 2The International Myeloma Foundation Reports Positive Shift In,Treatment Paradigm For Patients 3AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
... into the body more easily than any comparable sco...ching the lower pole calyces. Its smooth, lubricio...on of both scope and instruments. And its patented...us tip, and active secondary deflection deliver co...
...Ureteroscope permits direct visualization and acce... little or no dilation.,A tight bend radius and ...renal access, including the lower pole calyces. Du...reter and the renal pelvis. The 6.75 beveled tip f...
Smooth, contoured standard obturator provides less traumatic insertion through the urethra and into the bladder.
Electrohydraulic Lithotripsy Probe for AEH-4
Medicine Products: